Furthermore, here we have shown (Figure 4 and Figure 5) that treatment of cancer cells with hSELENOM resulted in the increased expression of a key marker of one of the three known UPR (unfolding protein response) signaling pathways—IRE1α. The gene discussed is ERN1; the disease is cancer.